Has Wendy Gamazo received payments from drug or device companies?

Yes. Drug and device makers reported $4,558 in general payments to Wendy Gamazo across 172 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Wendy Gamazo did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Wendy Gamazo come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Wendy Gamazo

Family · Miami, FLNPI 1538652136

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.1% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Abbott at 51.8% of the total. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,558in general payments, 2019–2025

Across 172 payments — averaging $26.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$2K
Medtronic$788
AbbVie$250
Pfizer$230
E.r. Squibb & Sons, L.L.C.$184
Sanofi-aventis U.S. LLC$166
plus $581 from 12 others

What the payments were for

Food & beverage$4,42697%
Education$1323%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	78	$2,360
Medtronic	37	$788
AbbVie	2	$250
Pfizer	13	$230
E.r. Squibb & Sons, L.L.C.	9	$184
Sanofi-aventis U.S. LLC	8	$166
Biotronik Inc.	2	$132
Kestra Medical Technology Services, Inc.	5	$99
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	4	$69
Novartis	2	$45
Vital Connect, Inc	2	$41
AstraZeneca	2	$39
Johnson & Johnson	2	$35
Cardiva Medical, Inc.	2	$30
Atricure, Inc.	1	$27
Philips North America LLC	1	$24
Cordis US CORP.	1	$19
Impulse Dynamics (USA) Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,558 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Metoprolol Succinate	13	$175
Amiodarone Hcl	12	$94

Paid to pharmacies, not to this prescriber.

Other family in Miami

Patrick SzarazMiami$327K
Yamila MelendezMiami$212K
Suzan RosenMiami$129K
Felipe NovoaMiami$110K
Pamela DudkiewiczMiami$89K
Stacy FeemsterMiami$51K
Estrella Moreno RodriguezMiami$30K
Lewis HarringtonTampa$954K
Danielle PharesFt Lauderdale$713K
Donna OrtizOrlando$417K

See the full list for Florida →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →